72 results
F-1
EX-3.1
SCNI
Scinai Immunotherapeutics Ltd
30 Oct 23
Registration statement (foreign)
4:59pm
will appoint among its members an audit committee. The number of members of the audit committee shall be no less than three and all of the external … directors shall be its members. The following will not be members of the audit committee: the chairperson of the Board of Directors, any director
6-K
EX-1.1
SCNI
Scinai Immunotherapeutics Ltd
19 Sep 23
Report of Foreign Private Issuer
3:06pm
, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.
(i) Material Changes; Undisclosed Events, Liabilities or Developments
6-K
EX-99.1
SCNI
Scinai Immunotherapeutics Ltd
12 Jul 23
Report of Foreign Private Issuer
12:00am
of the audit committee and the compensation committee. These requirements are in addition to the corporate governance requirements imposed by the listing … of the Companies Law regarding the election of external directors and to the composition of the audit committee and compensation committee, provided
6-K
SCNI
Scinai Immunotherapeutics Ltd
3 Jul 23
Report of Foreign Private Issuer
4:10pm
EXPLANATORY NOTE
The Audit Committee of the Board of Directors of BiondVax Pharmaceuticals Ltd. (the “Company”) recently conducted a process to select … period until the next annual general meeting of our shareholders. The Audit Committee invited a number of firms to participate in this process
10-Q
2023 Q1
EX-31.2
SCNI
Scinai Immunotherapeutics Ltd
15 May 23
Quarterly report
4:49pm
disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee
10-Q
EX-31.1
t89vn9c
15 May 23
Quarterly report
4:49pm
10-K
EX-14.1
ypz1tgote4i
17 Apr 23
Annual report
4:06pm
10-K
EX-31.1
xl0hko5oql0iuix2b9
17 Apr 23
Annual report
4:06pm
10-K
EX-3.1
u6s14wjlpb ma60eftfq
17 Apr 23
Annual report
4:06pm
10-K
5pg 4gymp
17 Apr 23
Annual report
4:06pm
10-K
EX-31.2
ro7rjj arl3dvyvup
17 Apr 23
Annual report
4:06pm
6-K
EX-1.1
zkig9k
20 Dec 22
BiondVax Announces Closing of $8 Million Underwritten Public Offering
5:29pm
424B4
gncpzed
20 Dec 22
Prospectus supplement with pricing info
11:59am
F-1/A
EX-3.1
xsz9kim2856
14 Dec 22
Registration statement (foreign) (amended)
4:45pm
F-1/A
EX-1.1
s963jqn
14 Dec 22
Registration statement (foreign) (amended)
4:45pm
F-1/A
qpabfr1xy5f lb4kc
12 Dec 22
Registration statement (foreign) (amended)
5:25pm
6-K
EX-99.1
7ih10w rqwpe
10 Nov 22
Current Report
5:28pm
F-1
9vsxp86g
29 Sep 22
Registration statement (foreign)
9:22am
6-K
EX-99.1
ryr5s967vpifef0jj0du
12 Apr 22
Report of Foreign Private Issuer
4:15pm